Ovid Therapeutics (OVID) Reports Q1 Loss, Tops Revenue Estimates
A quarter ago, it was expected that this company would post a loss of $0.16 per share when it actually produced a loss of $0.13, delivering a surprise of 18.75%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.
Ovid Therapeutics , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $0.13 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 96.97%. This compares to year-ago revenues of $0.15 million. The company has topped consensus revenue estimates three times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Ovid Therapeutics shares have lost about 67.7% since the beginning of the year versus the S&P 500's decline of -0.6%.
While Ovid Therapeutics has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Ovid Therapeutics: mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.14 on $0.09 million in revenues for the coming quarter and -$0.57 on $0.38 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Biomedical and Genetics is currently in the top 35% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, CureVac N.V. (CVAC), is yet to report results for the quarter ended March 2025.
This company is expected to post quarterly loss of $0.16 per share in its upcoming report, which represents a year-over-year change of +52.9%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
CureVac N.V.'s revenues are expected to be $14.47 million, up 7.7% from the year-ago quarter.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Ovid Therapeutics (OVID) : Free Stock Analysis Report
CureVac N.V. (CVAC) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
TSX futures steady as investors eye CPI data for clues on BoC rate path
(Reuters) -Futures tied to Canada's main stock index held steady on Tuesday, as investors awaited inflation data that could shape expectations for a potential rate cut by the country's central bank. The futures on the S&P/TSX index were up 0.12% as of 05:33 a.m. ET (0933 GMT), signaling a steady start to the S&P/TSX composite index after it ended marginally higher in the prior session. Economists polled by Reuters expect Canada's consumer price index report, due at 08:30 a.m. ET, to show a moderation in the annual inflation rate to 1.8% last month from 1.9% in June. The anticipated slowdown in inflation could incentivise the Bank of Canada to resume its policy easing cycle. The BoC had kept the benchmark rate on hold at 2.75% since March. Traders' bets, however, support a "hold" verdict at the central bank's September policy meeting, with odds for a cut standing at 31.4%. In corporate news, Air Canada's unionized flight attendants have reached an agreement with the country's largest carrier to end a strike, which had forced the airline to cancel flights and suspend its third-quarter and 2025 forecasts. Contact lens maker Bausch + Lomb said Brett Icahn and Gary Hu resigned from its board after termination of an agreement with billionaire investor Carl Icahn and certain affiliates. In commodities, oil prices slipped as investors evaluated a potential end to the war in Ukraine, which could lead to an end to sanctions on Russian crude. [O/R] Gold prices steadied ahead of the U.S. Federal Reserve's Jackson Hole symposium later this week for insights into the U.S. interest rate trajectory, while copper traded in a tight range. [GOL/] [MET/L] FOR CANADIAN MARKETS NEWS, CLICK ON CODES: TSX market report [.TO] Canadian dollar and bonds report [CAD/] [CA/] Reuters global stocks poll for Canada Canadian markets directory ($1 = 1.3818 Canadian dollars)
USA Today
31 minutes ago
- USA Today
US stock futures flat ahead of big box retailer results
U.S. stock futures are flat after a listless start to the week as investors stayed sidelined ahead of quarterly results from big box retailers and a conference of global financial leaders later this week. Discount giants Walmart and Target and home improvement company Lowe's are slated to report around midweek. Home Depot is due before the market opens. These earnings can provide a window into how tariffs are affecting companies and consumer spending. Federal Reserve Chair Jerome Powell is set to give a speech at the end of the week at the annual Jackson Hole Economic Symposium of global central bankers and finance chiefs. Investors will be looking for hints Powell may be done waiting to see tariff effects before cutting rates again. The CME FedWatch tool that shows the likelihood that the Fed will change rates at each policy meeting based on market trading suggests a nearly 84% chance of the Fed easing rates in September. Before Powell's speech, investors will get a glimpse midweek of the dissents at the last Fed meeting. Fed governors Christopher Waller and Michelle Bowman voted against the central bank's decision to keep rates unchanged between 4.25%-4.50% last month. It was the first time since 1993 that two governors dissented. At 6:10 a.m. ET, futures linked to the blue-chip Dow added 0.03%, while broad S&P 500 futures slipped -0.06% and tech-laden Nasdaq futures fell -0.05%. Corporate news Medora Lee is a money, markets and personal finance reporter at USA TODAY. You can reach her at mjlee@ and subscribe to our free Daily Money newsletter for personal finance tips and business news every Monday through Friday morning.
Associated Press
an hour ago
- Associated Press
Policy Crossroads: How Infrastructure Capital's ICAP ETF Could Be Well-Positioned Amid A Highly Public Power Struggle
By JE Insights, Benzinga DETROIT, MICHIGAN - August 18, 2025 ( NEWMEDIAWIRE ) - It may very well be the one hot macro topic that is on top of every investor's mind at the moment: the Federal Reserve's monetary policy and the potentially rising probability of benchmark interest rate cuts. Recently, betting markets revealed an anticipation of a dovish policy adjustment in September, prompting the President to apply pressure on the Fed chair. As the high-level conflict simmers, investors will want to pay close attention to Infrastructure Capital Equity Income ETF (ARCA: ICAP). Throughout this year, the president has repeatedly pushed for lower interest rates, under the basic theory that lower borrowing costs should help bolster consumption and commercial investments and endeavors. Following multiple calls for the central bank to implement a dovish monetary policy, U.S. Treasury Secretary Scott Bessent has been tasked with leading the search for a new Fed chair. Federal Reserve Chairman's term is set to expire in May 2025 and based on the current political trajectory, it's highly unlikely that he will serve another term. Still, many critics - including 'Shark Tank' investor - believe that Powell should be able to serve out his current term without political interference lest global trust in U.S. financial markets be undermined. Subsequently, the clash in Washington shines a spotlight on the ICAP vehicle. Structured as an exchange-traded fund, ICAP represents a financial product that seeks to maximize income and pursue total return opportunities. Broadly speaking, a holistic portfolio combines capital gains potential with passive income opportunities. In the post-pandemic paradigm, strength in the former element has been obvious to see, given the trailing five-year performance of the S&P 500 index. However, as the macro environment shifts, the latter component may rise to prominence. Why The ICAP ETF May Lose A Vexing Competitor In a capital-gains-heavy environment, growth companies are essentially competing with each other to vie for the most investor dollars. Obviously, there are limited resources and only the hottest, highest-perceived-potential enterprises have a shot at consistently accumulating a disproportionate share of said resources. It's a brutal game but it's also one of the fundamentally meritocratic concepts of free-market capitalism. However, when it comes to an income-oriented ecosystem, the calculus isn't quite as clear-cut. To be sure, dividend-paying companies certainly compete among themselves to attract investor dollars. Still, yield alone isn't necessarily the main trigger point that convinces market participants to take a risk. The reality is that if a company offers too generous a yield, that is more often a fiscal red flag than it is a confidence-inspiring invitation. Furthermore, what makes the investment narrative rather unique in an income-focused paradigm is that the government may impose significant competition on yield-generating assets, depending on the Fed's monetary policy. Essentially, government-backed debt securities - particularly the 10-Year U.S. Treasuries - generate risk-free yield. Technically, no financial security is absolutely devoid of downside threats. However, Treasuries are backed by the full faith and credit of Uncle Sam. By logical deduction, when this risk-free yield becomes excessively elevated relative to prior norms, there is a reduced incentive to acquire passive income from the commercial market. As it stands, the ICAP ETF offers an alternative mechanism for passive income, which many investors may find appealing - even with the historically high yield of 10-Year Treasuries. Overseen by financial services provider Infrastructure Capital, ICAP maximizes income by investing at least 80% of its net assets in a diversified portfolio of dividend-paying equity securities. Unlike passive ETFs that merely track benchmark indices, ICAP's fund management team expertly navigates complex market ecosystems. Informed by fundamental analysis and macroeconomic factors, the fund seeks out holistically robust opportunities while sidestepping the pitfalls that passive ETFs may blindly fall into. As of this writing, the 30 Day Sec Yield - Infrastructure Capital's standardized yield measure for its income fund - stands at 6.28%. That is competitive with the current yield of 10-Year Treasuries. However, government bonds enjoy the risk-free label, which investors often figure into their calculations. Of course, the political drama is what shines a relevant spotlight on the ICAP ETF. What has undergirded a major source of friction is that, according to some experts, Federal Reserve Chairman has broadcast a greater magnitude of hawkishness than many expected. Likely, this matter has only amplified the current administration's unrest toward Fed policy. Should the White House get its wishes, though, the pivot may spark renewed interest in higher-yielding commercial debt securities. A dovish monetary policy would imply a lower risk-free yield. At some point, the yield may fall too low, potentially inspiring a more speculative posture among income investors. With its active management and competitive yield, the ICAP ETF may make a pronounced case for itself. Getting Underneath The Hood Of The ICAP Income Fund From a structural and strategic standpoint, the ICAP ETF sets itself apart through its emphasis on high-yield equity income while maintaining diversified exposure. As mentioned earlier, the actively managed fund invests at least 80% of its funds in dividend-paying stocks. Within this framework, holdings span multiple market capitalizations, incorporating real estate investment trusts, financials, energy infrastructure and other income-generating equities to balance stability with opportunity. A central component of the ICAP ETF's mechanics is its flexible toolkit, which includes the potential use of options and modest leverage to enhance distributable income. Option strategies can serve as an additional income stream, though they require a disciplined approach to manage the inherent tail risks. The fund structure itself offers tax and cost efficiencies by meeting redemptions through in-kind transfers rather than security sales, helping to preserve capital gains and reduce turnover costs for investors. Steering these strategies is Jay D. Hatfield, founder, CEO and lead portfolio manager at Infrastructure Capital Advisors. With nearly three decades of capital markets experience spanning equity research, fixed income trading, energy infrastructure and real estate, Hatfield applies both macroeconomic insight and sector-level expertise to fund oversight. His management philosophy is rooted in a deep understanding of free cash flow generation from tangible assets, which he views as the backbone of sustainable income investing. Beyond the ICAP ETF, Hatfield also manages the Virtus InfraCap U.S. Preferred Stock ETF (NYSE: PFFA), where his disciplined focus on yield generation and risk-adjusted returns has earned broad attention. His cross-sector vantage point and prior work in both investment banking and hedge fund management give him the ability to position portfolios not just to react to prevailing market currents but to anticipate them. Moreover, under Hatfield's leadership, the ICAP ETF reflects a deliberate blend of income optimization, capital preservation and opportunistic growth potential - all framed within an active strategy that remains nimble in a shifting economic landscape. A Monetary Paradigm Shift Potentially Emerges While the ongoing tension between the White House and the Federal Reserve may offer media fodder, it underscores a deeper debate over the direction of monetary policy. With the administration openly pushing for lower interest rates, the clash extends beyond economic theory into questions of institutional independence and political influence. This dynamic introduces a layer of uncertainty for investors, as policy decisions could be shaped by both market conditions and the political calendar. Should the pressure result in a pivot toward more accommodative policy, the effects could be far-reaching. Lower benchmark rates would reduce the yield advantage of government debt, potentially prompting investors to reassess the balance between risk-free securities and other income-generating assets. In such a scenario, the competitive landscape for yield would shift, altering the relative appeal of equity-based income strategies. For ICAP, the intersection of these political and monetary forces could be significant. A dovish turn from the Fed would not only change the backdrop against which dividend-focused portfolios operate but could also influence how investors weigh yield, diversification and market exposure in the broader context of a recalibrated rate environment. You can view more details about ICAP here. Featured image fromShutterstock. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. This content was originallypublished on further disclosureshere. View the original release on
